These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9099453)

  • 1. The use of chemotherapy resistance in cancer treatment.
    Deisseroth AB; Pizzorno G
    Cancer J Sci Am; 1997; 3(2):60-9. PubMed ID: 9099453
    [No Abstract]   [Full Text] [Related]  

  • 2. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MDR (multidrug resistance) in hepatocarcinoma clinical-therapeutic implications].
    Petraccia L; Onori P; Sferra R; Lucchetta MC; Liberati G; Grassi M; Gaudio E
    Clin Ter; 2003; 154(5):325-35. PubMed ID: 14994922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene rearrangement: a novel mechanism for MDR-1 gene activation.
    Mickley LA; Spengler BA; Knutsen TA; Biedler JL; Fojo T
    J Clin Invest; 1997 Apr; 99(8):1947-57. PubMed ID: 9109439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of multidrug resistance and apoptosis of cancer cells by selected carotenoids.
    Molnár J; Gyémánt N; Mucsi I; Molnár A; Szabó M; Körtvélyesi T; Varga A; Molnár P; Tóth G
    In Vivo; 2004; 18(2):237-44. PubMed ID: 15113052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D; Dekel Y; Melikhov D; Margalit R
    Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Criteria of measuring mdr-1 gene expression level in breast cancer by RT-PCR].
    Liu X; Song S; Shi C
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):38-41. PubMed ID: 10743053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
    Kaye SB
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene therapy using anticancer drug-resistance genes].
    Sugimoto Y
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):1-9. PubMed ID: 9987494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells.
    Conze D; Weiss L; Regen PS; Bhushan A; Weaver D; Johnson P; Rincón M
    Cancer Res; 2001 Dec; 61(24):8851-8. PubMed ID: 11751408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of expression of multidrug resistance gene in breast cancer tissue].
    Liu X; Song S; Shi C
    Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):488-90. PubMed ID: 9772445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of cancer multidrug resistance by green tea polyphenols.
    Mei Y; Qian F; Wei D; Liu J
    J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mdr1 promoter-driven tumor necrosis factor-alpha expression for a chemotherapy-controllable combined in vivo gene therapy and chemotherapy of tumors.
    Walther W; Stein U; Fichtner I; Alexander M; Shoemaker RH; Schlag PM
    Cancer Gene Ther; 2000 Jun; 7(6):893-900. PubMed ID: 10880020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Employment of the mdr1 promoter for the chemotherapy-inducible expression of therapeutic genes in cancer gene therapy.
    Walther W; Wendt J; Stein U
    Gene Ther; 1997 Jun; 4(6):544-52. PubMed ID: 9231070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance: molecular and clinical aspects.
    Dicato M; Duhem C; Pauly M; Ries F
    Cytokines Cell Mol Ther; 1997 Jun; 3(2):91-9. PubMed ID: 9287248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous genetic chemoprotection of normal marrow cells and genetic chemosensitization of breast cancer cells in a mouse cancer gene therapy model.
    Hanania EG; Deisseroth AB
    Clin Cancer Res; 1997 Feb; 3(2):281-6. PubMed ID: 9815684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1.
    Yagüe E; Higgins CF; Raguz S
    Gene Ther; 2004 Jul; 11(14):1170-4. PubMed ID: 15164094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the typical multidrug resistance phenotype by targeting the MED-1 region of human MDR1 promoter.
    Marthinet E; Divita G; Bernaud J; Rigal D; Baggetto LG
    Gene Ther; 2000 Jul; 7(14):1224-33. PubMed ID: 10918491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of multidrug resistance gene mdr1 and cancer resistance to chemotherapy by the longevity gene sirt1.
    Chu F; Chou PM; Zheng X; Mirkin BL; Rebbaa A
    Cancer Res; 2005 Nov; 65(22):10183-7. PubMed ID: 16288004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.